# A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

> **NCT06670209** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 32 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** GZR18 and metformin

## Key facts

- **NCT ID:** NCT06670209
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2025-03-19
- **Final completion:** 2025-03-19
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06670209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06670209, "A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06670209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*